• Bioavailability evaluation of µSMIN™ Plus , an innovative bio-enhanced form of micronized diosmin, in rats (study completed; manuscript in process).

 

  • Doulble-blind, placebo controlled, randomized clinical trial to assess probiotics presence on vaginal mucosa after oral administration of Respecta®(study published).

 

  • In vitro anti-microbial activity of Respecta® against vaginal pathogens Gardnerella vaginalis and Atopobium vaginae (study completed).